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Burkholderia pseudomallei and Burkholderia mallei are closely related Gram-negative
bacteria responsible for the infectious diseases melioidosis and glanders, respectively.
Autotransporters (ATs) comprise a large and diverse family of secreted and outer mem-
brane proteins that includes virulence-associated invasins, adhesins, proteases, and actin-
nucleating factors.The B. pseudomallei K96243 genome contains 11 predicted ATs, eight
of which share homologs in the B. mallei ATCC 23344 genome. This review distils key
ﬁndings from in silico, in vitro, and in vivo studies on the ATs of B. pseudomallei and B.
mallei.To date, the best characterized of the predictedATs of B. pseudomallei and B. mallei
is BimA, a predicted trimeric AT mediating actin-based motility which varies in sequence
and mode of action between Burkholderia species. Of the remaining eight predicted B.
pseudomallei trimeric autotransporters, ﬁve of which are also present in B. mallei,t w o
(BoaA and BoaB), have been implicated in bacterial adhesion to epithelial cells. Several
predicted Burkholderia ATs are recognized by human humoral and cell-mediated immunity,
indicating that they are expressed during infection and may be useful for diagnosis and
vaccine-mediated protection. Further studies on the mode of secretion and functions of
Burkholderia ATs will facilitate the rational design of control strategies.
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BURKHOLDERIA PSEUDOMALLEI AND BURKHOLDERIA
MALLEI
Melioidosis,a febrile illness with disease states ranging from acute
pneumonia or septicemia to chronic or localized abscess for-
mation, was ﬁrst documented by Whitmore and Krishnaswami
(1912). The causative agent, Burkholderia pseudomallei, was sub-
sequently identiﬁed as a motile, Gram-negative bacillus, which
is principally a saprophyte found in soil and water in subtropi-
cal areas. The disease is acquired by inhalation, aspiration, sub-
cutaneously, or occasionally via ingestion. Most cases occur in
patients with immunosuppression, especially those with diabetes
mellitus. Melioidosis has become an increasingly important dis-
ease in endemic areas such as South-East Asia and Northern
Australia causing a signiﬁcant number of deaths despite antibi-
otic treatment. Furthermore,B. pseudomallei is also recognized as
a pathogen of numerous animal species (reviewed in Lazar Adler
et al.,2009; Galyov et al., 2010).
Burkholderia mallei is closely related to B. pseudomallei and
is the etiological agent of Glanders, an infectious equine disease
that can be transmitted to humans. The disease may be acute or
chronic,withthechronicformusuallyoccurringinhorsesandthe
acuteformoccurringinmulesanddonkeys.Clinicalsignsinclude
swollen lymphatics,a chronic nasal discharge,and ulcers. Contact
with nasal discharge or infected ulcers is a major risk factor for
infection. B. mallei is adapted to a narrower range of hosts than B.
pseudomallei and is not considered able to persist for protracted
periods in the environment. Horses are the primary carriers of
disease and are largely responsible for transmission. Infections in
humans frequently involve sepsis, pneumonia and abscess forma-
tion and have a high mortality rate. The incubation period ranges
fromdaystoweeks,andanimalscandiewithinaweekof theonset
of clinical symptoms (reviewed in Whitlock et al., 2007; Galyov
et al.,2010).
THE AUTOTRANSPORTER FAMILY
Autotransporters (ATs) are a large and diverse family of bacterial
secretedandoutermembrane(OM)proteinsthataretranslocated
from the bacterial cytoplasm via the TypeV pathway,one of seven
recognizedsecretionpathwaysinGram-negativebacteria.ATsplay
diverse roles, and many such proteins inﬂuence pathogenesis and
immunity, for example by acting as invasins, adhesins, proteases,
or actin-nucleating factors. ATs typically consist of a 20–400-kDa
passenger domain that contains the effector functions and a 10–
30-kDaβdomainfacilitatingtranslocationacrosstheOM(Dautin
and Bernstein,2007). ATs can be further divided into classical ATs
andtrimericautotransportedadhesins(TAAs),referredtoasType
Va and Type Vc respectively. TAAs have a coiled-coil motif of
unknown function, and are therefore referred to as oligomeric
coiled-coil adhesins (Oca). Trimerization of TAAs is essential for
theirtranslocationandfunctionasasingleβbarrelisformedfrom
the three shorter 4-stranded β barrel domains which is superim-
posable with the classicalATs 12-stranded β barrel.While classical
ATshavediverseeffectorfunctions,allcharacterizedTAAs,withthe
notable exception of BimA from Burkholderia spp., are adhesins
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(Cotter et al., 2005; Dautin and Bernstein, 2007). The threefold
symmetry provides the potential for a multivalent interaction to
enhanceavidity,whichcouldovercomemechanicalforcesandpro-
vide stability against proteases and detergents within extracellular
secretions (Cotter et al., 2005).
Despite diversity in sequence, length, and function of the pas-
senger domains, most ATs are variations on a single structural
theme: an elongated solenoid (a coil wound into a tightly packed
helix) which may contribute to protein folding after transport
and/or allow effector domains to traverse LPS and capsule lay-
ers. This conserved shape creates a scaffold for various loops and
domainswithoutdisturbingstructuralintegrityandallowsmulti-
pleinterfacestomediateinteractions(Wellsetal.,2007;Nishimura
et al., 2010). Classical ATs form a right-handed β helical structure
while TAAs have a β roll (two β strands contributing to a sin-
gle superhelical turn);these structural differences affect curvature
and binding speciﬁcity (Dautin and Bernstein, 2007). However,
the recent full structure for the Pseudomonas aeruginosa classical
ATEstAdemonstratedanexceptiontothesolenoidstructure,with
a α-β-α globular fold (Van Den Berg, 2010), which may relate to
its function as a lipase rather than an adhesin.
ATsmustcrossbothplasmamembranesof Gram-negativebac-
teria. Classical ATs are then predominantly cleaved for secretion
intotheextracellularmilieuwhereasTAAsremainintegratedinthe
bacterial OM via their β barrel domain. Firstly,ATs are targeted to
the IM by their N-terminal signal sequence, where translocation
occurs via the general secretory (Sec) pathway. The N-terminal
signal sequence ranges from 20 to 60 aa, with the most elongated
signal peptides being associated with large (>1000 aa) passenger
domains in TAAs (Dautin and Bernstein, 2007). Such extended
signal peptides exhibit reduced interaction with the Sec com-
plexpromotingdelayedpost-translationaltranslocationacrossthe
innermembranewhichisproposedtoallowpartialfoldingforsub-
s e q u e n tO Ms e c r e t i o n( Peterson et al.,2006;Desvaux et al.,2007).
Once in the periplasm, ATs can undergo modiﬁcations including
glycosylation and lipidation and may also form disulﬁde bonds.
As implied in their name, ATs were originally believed to medi-
ate their own transport across the OM. However, recent research
suggests that they are chaperoned by periplasmic proteins,such as
SurA and DegP to the Bam (Omp85) complex located within the
OMwhichmayassistintranslocation(Oomenetal.,2004;Dautin
and Bernstein, 2007). Several ATs have been shown to interact
directly with the Bam complex (Ieva and Bernstein, 2009; Sauri
et al., 2009; Lehr et al., 2010), as well as periplasmic chaperones
including SurA and DegP (Ieva and Bernstein, 2009; Ruiz-Perez
et al., 2009). Furthermore, depletion of the essential BamA pro-
tein signiﬁcantly affects AT secretion (Jain and Goldberg, 2007).
BamA forms a 16-strand β barrel with a pore size of ∼2.5nm
which is signiﬁcantly larger than the AT β barrel (∼1.2nm) and
would allow for translocation of partially folded ATs. Addition-
ally,BamAoligomerizesinvitro andcouldpossiblyformoligomer
porescapableof translocatingfoldedATs.Theseobservationshave
led to two hypotheses: translocation of the unfolded passenger
domain through the Bam-stabilized AT β barrel via a hairpin cur-
vature or translocation of the entire AT, possibly partially folded,
via the Bam complex (Sauri et al., 2009). Structural analysis indi-
cates that sequential folding of the passenger domain may act as
the driving force for translocation of AT (Van Den Berg, 2010),
although evidence suggests that partially folded or misfolded ATs
are still capable of translocation (Dautin and Bernstein, 2007).
Therefore, the translocation of ATs is dependent on periplasmic
chaperonesandtheBamcomplexviaamechanismwhichremains
to be elucidated but which appears to be mediated by interac-
tion with the β domain of the ATs. This would account for the
observation that the C-terminal domains of TAAs from diverse
bacterial species are functionally interchangeable (Ackermann
et al.,2008).
AUTOTRANSPORTERSOFB.PSEUDOMALLEI ANDB.MALLEI
The B. pseudomallei K96243 genome contains 11 predicted ATs,
annotated as such based on sequence similarity to known ATs
(Table 1). Additionally, 10 of these ATs are conserved across the
other three completed B. pseudomallei genomes, while BPSL1705
is missing from both the 1106a and 688 strains. The B. mallei
ATCC 23344 genome has eight homologs of the B. pseudomallei
ATs (Table 1).Sixoftheseareconservedacrossthethreeadditional
B. mallei completed genomes, with BMA1027 being present only
inB.malleiATCC23344,whiletheavirulentB.mallei SAVPIstrain
also lacks BMAA0649. Homologs for seven of the B. pseudomallei
ATsarealsofoundinavirulentB.thailandensis (Table 1).However,
we caution that conservation of loci in pathogenic Burkholderia
and B. thailandensis does not necessarily imply that the genes play
no role in virulence or host cell-interactions, as demonstrated by
our analysis of the bsa Type III secretion locus shared by such
strains (Stevens et al., 2002, 2004). Only two ATs are predicted
to be classical ATs: BPSS0962/BMAA1263 (a putative serine pro-
tease) and BPSL2237/BMA1647 (a putative lipase/esterase). The
remainderarepredictedTAAs(Tiyawisutsrietal.,2007).Aninsil-
ico subtractivehybridizationofpathogenicversusnon-pathogenic
Burkholderia species to generate a 650 gene virulome, identiﬁed
six ATs (BPSS0962, BPSL2237, BPSL1631, BPSL2063, BPSS796,
BPSS0908; Schell et al., 2008). Furthermore, a “gain of function”
genomic library screen identiﬁed ﬁve ATs as having a possible
role in invasion and survival within macrophages (BPSL1705,
BPSL2237,BPSS0088,BPSS0796,BPSS1492;Dowlingetal.,2010).
NeitherapproachidentiﬁedacommonsetofdominantATs,which
may indicate that the ATs have a cumulative importance. How-
ever, direct experimental evidence for a role of ATs in virulence
or intramacrophage survival, as proposed by Schell et al. (2008)
and Dowling et al. (2010), is lacking at the time of writing. Sev-
eral predicted ATs are recognized by human convalescent sera, in
some cases with a speciﬁcity adequate for serodiagnosis,and such
data indicate that the proteins are expressed in vivo (Tiyawisut-
sri et al., 2007; Felgner et al., 2009; Suwannasaen et al., 2011).
To date, the best characterized of the predicted ATs of B. pseudo-
mallei and B. mallei is a factor inﬂuencing intracellular motility,
BimA.
BURKHOLDERIA INTRACELLULAR MOTILITY AND THE BIMA
PROTEIN
In common with selected species of Listeria, Shigella, Rickettsia,
and Mycobacterium marinum, B. pseudomallei shares the abil-
ity to induce polymerization of actin at one pole of the bac-
terial cell to promote its movement within and between host
cells (Figure 1). The formation of actin-rich bacteria-containing
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Table 1 | Autotransporters of B. pseudomallei K96243 and B. mallei ATCC 23344.The 11 B. pseudomallei ATs and their eight B. mallei
homologs are listed below alongside relevant functional information.
Bp K96243 BmATCC 23344 Size (aa) Annotation Biological characteristics
Classical autotransporters
BPSL2237* BMA1647 610, 610
BPSS0962* BMAA1263 1131, 1129
Trimeric autotransporter adhesins
BPSL1631 BMA1027 1124, 1012 Immunogenic (Bm;Tiyawisutsri et al., 2007)
BPSL1705 – 1606 BoaB Adhesin (Balder et al., 2010)
BPSL2063 BMA0840 1090, 1090 Immunogenic (Bp, Bm;Tiyawisutsri et al., 2007)
BPSS0088* – 1645 Serodiagnostic (Felgner et al., 2009)
BPSS0796 BMAA0649 1653, 1535 BoaA Adhesin (Balder et al., 2010), immunogenic (Bp, Bm;Tiyawisutsri et al., 2007)
BPSS0908* BMAA1324* 1324, 831 Serodiagnostic (Felgner et al., 2009), immunogenic (Bp, Bm;Tiyawisutsri et al., 2007)
BPSS1434* – 2634 BpaA CharacteristicTAA head crystal structure (Edwards et al., 2010), serodiagnostic
(Felgner et al., 2009)
BPSS1439* BMAA0810*ˆ 1530, 459ˆ Immunogenic (Bp;Tiyawisutsri et al., 2007)
BPSS1492* BMAA0749* 516, 373 BimA Actin-based motility (Stevens et al., 2005b), serodiagnostic (Felgner et al., 2009),
immunogenic (Bp;Tiyawisutsri et al., 2007)
*B. thailandensis homolog identiﬁed in E264 genome.
ˆPutative pseudogene.
FIGURE 1 |Actin-based motility of B. pseudomallei in a J774.2 murine
macrophage-like cell 8h post-infection. B. pseudomallei was detected
with antibodies to its lipopolysaccharide (green) and BimA was detected
with a panel of speciﬁc monoclonal antibodies (blue). Polymerized (F-) actin
was stained red with ﬂuorophore-labeled phalloidin.
membrane protrusions was ﬁrst described in B. pseudomallei-
infectedHeLaandJ774.1cells(Kespichayawattanaetal.,2000),but
isalsoafeatureof B.mallei andB.thailandensis infection(Stevens
et al., 2005a). The bacterial factor(s) required for actin-based
motilityof B.pseudomallei havebeensoughtbyscreeningrandom
mutants for a small plaque phenotype (Pilatz et al., 2006) and by
targeted inactivation of candidate factors (Stevens et al., 2005b).
Onesuchcandidate(BPSS1492,BimA)belongstotheOca/typeVc
familyofTAAswithaβbarrelsequenceandlinkerregionwith48%
similarity to the Y. enterocolitica YadA C-terminal (pfam domain
03895). This was targeted on the basis that Shigella and Rickettsia
useATs for actin-based motility (IcsA and Sca2,respectively). The
predicted BPSS1492 protein also contained domains associated
with actin binding, including proline-rich motifs and Wiskott–
Aldrich syndrome protein (WASP) homology-2 (WH2) domains
that suggested it may be involved in actin assembly (Stevens et al.,
2005b).Actin-basedmotilityof B.pseudomallei inJ774.2cellswas
abolished by inactivation of bimA and could be restored by tran-
sient expression of the gene in trans (Stevens et al., 2005b). BimA
is located at the pole of the bacterial cell at which actin polymer-
izationoccursandpolarlocalizationisfrequentlyseeninonlyone
daughter cell at division (Figure 1), implying that polar targeting
of BimA may rely on distinguishing the new and old poles of the
cell (Stevens et al., 2005b).
Burkholderia pseudomallei BimA possesses an unusually long
signal sequence typical of autotransporters and a passenger
domain containing several putative functional domains. Within
this effector domain, the two WH2 motifs have each been found
to inﬂuence actin binding and polymerization in vitro (Sitthidet
etal.,2011).Inaddition,B.pseudomallei BimAcontainsbetween2
and 7 predicted target sites for host cell casein kinase II (PDASX),
with variation across sequenced strains (Sitthidet et al., 2008).
The PDASX repeats have since been established to act in an addi-
tive manner to enhance actin polymerization in vitro (Sitthidet
et al.,2011). It remains unclear if such repeats are phosphorylated
in vivo,or what the functional consequences of post-translational
modiﬁcation of BimA may be. Interestingly a 13 aa repeat region
of BimA was found to be required for intercellular spread of B.
pseudomallei but was dispensable for actin binding and polymer-
ization (Sitthidet et al., 2011). Other bacterial factors involved in
actin-based motility have been shown to promote intracellular
survival through evasion of cytosolic killing by autophagy and
further studies with deﬁned mutants are required to determine if
BimA or its domains confer such activity.
BimA orthologs exist in B. mallei ATCC23344 (BMAA0749)
and B. thailandensis E264 (BTH_II0875) and can restore actin-
based motility of a B. pseudomallei bimA mutant (Stevens et al.,
2005a). The BimA passenger domain of the three species differ
markedly in primary sequence resulting in differences in the
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number of WH2 domains, sequence of proline-rich motifs and
the presence of a central and acidic (CA) domain, indicating that
they may initiate actin assembly by distinct mechanisms (Stevens
et al., 2005a). Many mechanisms of bacterial actin-based motility
converge on activation of the cellular Arp (actin-related protein)
2/3 complex. Activation of the Arp2/3 complex requires cellular
nucleation-promotingfactors(NPFs)suchasWASP-familymem-
bers, and pathogens capable of actin-based motility often mimic
the activity of NPFs or recruit and activate them at the bacterial
pole (reviewed in Stevens et al., 2006). In recent years however,
a number of virulence-associated factors have been identiﬁed in
bacteria that initiate actin assembly in an Arp2/3-independent
manner. For example, the AT Sca2 facilitates actin-based motil-
ity of certain Rickettsia species in anArp2/3-independent manner
akin to cellular formin proteins (Haglund et al., 2010; Kleba
et al., 2010). It is notable that truncated recombinant B. pseudo-
mallei BimA puriﬁed from E. coli polymerizes actin in vitro in
the absence of any other cellular and bacterial co-factor in an
Arp2/3-independentmanner(Stevensetal.,2005b;Sitthidetetal.,
2010); however,it remains unclear if such intrinsic activity would
be adequate to propel the bacteria inside cells. In contrast, the
ability of the B. thailandensis BimA ortholog to assemble actin
in vitro is Arp2/3-dependent and requires the Arp2/3-recruiting
CA domain (Sitthidet et al., 2010). Little is presently known
about the mechanism of action of the B. mallei BimA ortholog;
however, it is considered unlikely to be Arp2/3-dependent as it
lacks an invariant tryptophan residue within an acidic stretch
of residues required for Arp2/3 binding and activation (Stevens
et al.,2005b). Intra-species conservation of BimA in natural pop-
ulations of B. pseudomallei and B. thailandensis is high, with the
exception of a geographically restricted subset of B. pseudomallei
isolates harboring a B. mallei-like BimA variant (Sitthidet et al.,
2008, 2010). The impact of sequence variation within BimA on
pathogenesis and recognition by host immunity remains to be
elucidated.
BimAhasattractedmuchinterestasadiagnostictool.Recently,
researchers have developed PCR-based methods to discriminate
between Burkholderia species in a clinical setting (Ulrich et al.,
2006a,b; Sitthidet et al., 2011), and protein microarray studies
led to inclusion of BimA in a 10-protein multiplex classiﬁer to
improve diagnosis of human B. pseudomallei infection (Felgner
et al., 2009; Suwannasaen et al., 2011). Curiously the B. mallei
BimA protein was non-immunogenic in a test with serum fromB.
mallei-infectedhorses(Tiyawisutsri et al.,2007),yetB.pseudoma-
llei BimA is one of the most immunogenic proteins recognized
by sera from convalescent melioidosis patients (Felgner et al.,
2009; Suwannasaen et al., 2011) and also serves as a T cell anti-
gen (Felgner et al., 2009; Suwannasaen et al., 2011). The role
of BimA in the pathogenesis and virulence of B. mallei and B.
pseudomallei also appears to differ, with B. mallei BimA being
dispensable for virulence in a Syrian hamster model of glan-
ders (Schell et al., 2007) whilst B. pseudomallei BimA contributes
to pathogenesis in murine models of melioidosis and confers
protection against homologous challenge (Galyov et al., unpub-
lished data). This may reﬂect differences in the animal species,
dose and route of inoculation. BimA in B. mallei is regulated by
the VirAG two-component system that is encoded nearby and
which also controls expression of a virulence-associated Type
VI secretion system (Schell et al., 2007). BimA appears to be
poorly expressed in vitro and the stimuli for its expression are
ill-deﬁned.
CHARACTERIZATION OF OTHER CANDIDATE
B. PSEUDOMALLEI AND B. MALLEI AUTOTRANSPORTERS
In addition to BimA, two predicted TAAs have been the subject
of furthercharacterization:BPSS0796/BMAA0649andBPSL1705,
re-annotated as BoaA and BoaB respectively, were expressed in a
heterologous E. coli host where they were displayed on the bac-
terial surface and promoted attachment of the recombinant E.
coli strains to epithelial cell lines (Balder et al., 2010). In com-
mon with the role of other TAA family members in adherence, B.
pseudomallei and/or B. mallei mutants with disruptions in boaA
or boaB exhibited reduced adherence to epithelial cells and a dou-
ble mutant, but neither single mutant, displayed a growth defect
in phagocytic cell lines (Balder et al., 2010). Though suggestive of
a role in virulence, studies with deﬁned mutant and repaired or
complemented strains in animals are required to establish the role
of BoaA and BoaB in pathogenesis.
Evidence of expression of selected TAAs has been obtained by
screening of expression libraries with convalescent sera. Serum
from B. mallei-infected horses identiﬁed multiple independent
clones for four TAAs (BMA0840, BMA1027, BMA0649, and
BMAA1324) suggestive of a strong antibody response (Tiyaw-
isutsri et al., 2007). A similar screen with convalescent serum
from human melioidosis patients identiﬁed ﬁve TAAs (BPSL2063,
BPSS0908, BPSS0796, BPSS1439, and BPSS1492); however, these
were found at a low frequency indicative of a relatively poor
immune response (Tiyawisutsri et al., 2007). Further studies
are required to determine if this reﬂects genuine differences in
immunogenicity of the predicted proteins, or the distinct hosts,
nature of exposure and/or sampling times.Additionally,a protein
microarrayprobedwithpooledmelioidosispatientsseraidentiﬁed
4 ATs (BPSS0088, BPSS0796, BPSS1434/BpaA, BPSS1492/BimA)
as having serodiagnostic potential due to their ability to inter-
act with melioidosis-speciﬁc antibodies (Felgner et al., 2009).
The ATs identiﬁed by these two studies demonstrate minimal
overlap although this may reﬂect the variation in in vivo bac-
terial gene expression or the host immune response. Microar-
ray studies under 82 in vitro different conditions demonstrated
that the 11 ATs of B. pseudomallei are constitutively expressed
(Tan, personal comm.), while qRT-PCR analysis of the transcrip-
tion of two AT genes (boaA, boaB) demonstrated low expression
(Balder et al., 2010).
Alignment of the C-terminal β barrel domain regions of the
putativeB.pseudomallei andB.mallei TAAsdemonstratesconsid-
erable conservation indicative of ampliﬁcation of these adhesins
through gene duplication events (Figure 2A). This is potentially
signiﬁcant given the importance of C-terminal regions of TAAs in
translocationandtrimerstability,asevidencedbytheabilityof C-
terminal domains of YadA family members from diverse bacteria
tofunctionallyreplacethecognatedomaininYersinia (Ackermann
et al., 2008). A phylogenetic tree of the β barrel domains is sup-
portive of this idea as the TAAs form two clusters suggesting that
these genes may have been ampliﬁed from two original ancestral
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FIGURE 2 |Alignment and phylogenetic analysis of the β barrel
domains of the putative B. pseudomallei and B. mallei TAAs:
(A) the nine B. pseudomallei C-terminal 70–72 aa β barrel domains
(B. mallei homologs 100% identical at this region) were
aligned; identical residues are highlighted in red, those with
high homology (at least 66%) in blue while those with highly
conserved substitutions in green.The consensus sequence is listed below.
(B)The phylogenetic analysis of these domains demonstrates two distinct
clusters both of which derived from a common ancestor to the prototypical
YersiniaYadATAA.
genes (Figure 2B). Both clusters appear to be derived from a
common ancestor to the prototypic Yersinia YadA TAA. Addi-
tionally, the two outliers in the alignment, BPSS0908/BMAA1324
and BPSS1434, display early separation in the phylogenetic tree.
Interestingly, of the three unique B. pseudomallei TAAs, two
(BPSS1434 and BPSS0088) are early branches in the phyloge-
netic tree suggesting that their absence from B. mallei is due
to gene loss as later branching genes are present. Meanwhile
BPSL1705,which is located within a genomic island (GI8),is very
recently branched from BPSS0796/BMAA0649 and has been pro-
posedtohaveoriginatedasaduplicationofBPSS0796/BMAA0649
(Tiyawisutsri et al., 2007). This duplication event may explain
why BPSL1705 is the only AT not conserved across the four
completed B. pseudomallei genomes. Furthermore, the β barrel
domains of the B. pseudomallei and B. mallei TAA homologs
show 100% identity although little similarity is seen between
the passenger domains. However, the effector domains of TAAs
are generally not conserved at a sequence level and the crys-
tal structure analysis of a section of the passenger domain of
BPSS1434 (re-annotated as BpaA, B. pseudomallei adhesion A)
demonstrated quaternary structure similar to that of other TAAs
(Edwards et al., 2010). This new annotation gives BPSS1434 the
same name as the unrelated Type V two-partner secreted BpaA
(Brown et al., 2004) for which no homolog exists in either B.
pseudomallei K96243 or B. mallei ATCC 23344. The B. pseudo-
mallei and B. mallei genomes contain homologs of BamA, BamB,
and SurA which are proposed to assist in translocation of ATs
across the OM (Ieva and Bernstein, 2009; Ruiz-Perez et al., 2009;
Sauri et al., 2009; Lehr et al., 2010), and further studies are
needed to evaluate the role of such factors in AT secretion and
pathogenesis.
CONCLUDING REMARKS
On the basis of homology and the precedent of phenotypes for
AT mutants in other bacteria, it is reasonable to infer that ATs
predicted to be encoded in the genomes of pathogenic Burkholde-
ria species may play a role in pathogenesis and immunity. In the
short time since annotation of the genomes of B. pseudomallei
and B. mallei, it has been established that several putative ATs
mediate bacterial interactions with host cells. For example, BimA
mediates intracellular actin-based motility, which in the case of
B. pseudomallei is necessary for intercellular spread and full vir-
ulence, whereas BoaA and BoaB appear to function as adhesins.
One should note that signiﬁcant sequence divergence in effector
domains can occur even among closely related species,and within
species, as we have noted for BimA (Sitthidet et al., 2008). Such
variation in BimA can markedly alter the mode of action (Sit-
thidet et al., 2011) and future studies will need to consider the
extent to which the repertoire and sequence of ATs in prototype
strains is typical of wider populations.Very few published studies
have probed the role of ATs in pathogenesis or immunity dur-
ing B. pseudomallei and B. mallei infection in model hosts, and
further studies with deﬁned mutants and complemented strains
areneeded.Attenuatedmutantsmaybesuitableaslive-attenuated
vaccines,andbasedontheabilityofsomeATstoactasB-andT-cell
antigens (Tiyawisutsri et al.,2007),puriﬁedATs may have merit as
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subunit vaccines or as diagnostic tools. Importantly, the mode of
translocation of Burkholderia ATs is inferred only from homolo-
goussystems,andstudiesareneededtoaddressoutstandingques-
tions regarding their biological role. Future experiments should
evaluate the role of AT domains and speciﬁc residues in protein
folding, oligomerization, interaction and translocation across the
OM, with particular reference to the requirement for periplasmic
chaperones and the Bam complex. Analysis of the structure of
Burkholderia ATs may also provide clues to the mechanistic basis
of their secretion and function.
REFERENCES
Ackermann, N., Tiller, M., Anding,
G., Roggenkamp, A., and Heese-
mann, J. (2008). Contribution of
trimericautotransporterC-terminal
domains of oligomeric coiled-coil
adhesin (Oca) family members
YadA, UspA1, EibA, and Hia to
translocation of the YadA pas-
senger domain and virulence of
Yersinia enterocolitica. J. Bacteriol.
190, 5031–5043.
Balder,R.,Lipski,S.,Lazarus,J.J.,Grose,
W., Wooten, R. M., Hogan, R. J.,
Woods, D. E., and Lafontaine, E. R.
(2010). Identiﬁcation of Burkholde-
ria mallei and Burkholderia pseudo-
mallei adhesins for human respira-
tory epithelial cells. BMC Microbiol.
10, 250. doi: 10.1186/1471-2180-
10-250
Brown, N. F., Logue, C. A., Boddey,
J. A., Scott, R., Hirst, R. G., and
Beacham,I.R.(2004).Identiﬁcation
of a novel two-partner secretion
system from Burkholderia pseudo-
mallei. Mol. Genet. Genomics 272,
204–215.
Cotter,S.E.,Surana,N.K.,andStGeme,
J. W. R. (2005). Trimeric autotrans-
porters:adistinctsubfamilyof auto-
transporter proteins. Trends Micro-
biol. 13, 199–205.
Dautin, N., and Bernstein, H. (2007).
Protein secretion in Gram-negative
bacteria via the autotransporter
pathway. A n n u .R e v .M i c r o b i o l .61,
89–112.
Desvaux, M., Scott-Tucker, A., Turner,
S. M., Cooper, L. M., Huber, D.,
Nataro, J. P., and Henderson, I. R.
(2007). A conserved extended signal
peptide region directs posttransla-
tional protein translocation via a
novelmechanism.Microbiology 153,
59–70.
Dowling,A.J.,Wilkinson,P.A.,Holden,
M. T., Quail, M. A., Bentley, S. D.,
Reger, J., Waterﬁeld, N. R., Titball,
R. W., and Ffrench-Constant,
R. H. (2010). Genome-wide
analysis reveals loci encoding anti-
macrophage factors in the human
pathogen Burkholderia pseudomallei
K96243. PLoS ONE 5, e15693.
doi: 10.1371/journal.pone.0015693
Edwards, T. E., Phan, I., Abendroth,
J., Dieterich, S. H., Masoudi, A.,
Guo, W., Hewitt, S. N., Kelley, A.,
Leibly, D., Brittnacher, M. J., Staker,
B. L., Miller, S. I., Van Voorhis,
W. C., Myler, P. J., and Stew-
art, L. J. (2010). Structure of a
Burkholderia pseudomallei trimeric
autotransporter adhesin head. PLoS
ONE 5, e12803. doi: 10.1371/jour-
nal.pone.0012803
Felgner, P. L., Kayala, M. A., Vigil, A.,
Burk,C.,Nakajima-Sasaki,R.,Pablo,
J.,Molina,D.M.,Hirst,S.,Chew,J.S.,
Wang,D.,Tan,G.,Dufﬁeld,M.,Yang,
R.,Neel,J.,Chantratita,N.,Bancroft,
G., Lertmemongkolchai, G., Davies,
D. H., Baldi, P., Peacock, S., and
Titball, R.W. (2009). A Burkholde-
ria pseudomallei protein microar-
ray reveals serodiagnostic and cross-
reactive antigens. Proc. Natl. Acad.
Sci. U.S.A. 106, 13499–13504.
Galyov, E. E., Brett, P. J., and DeS-
hazer, D. (2010). Molecular insights
into Burkholderia pseudomallei and
Burkholderia mallei pathogenesis.
A n n u .R e v .M i c r o b i o l .64, 495–517.
Haglund, C. M., Choe, J. E., Skau, C.
T., Kovar, D. R., and Welch, M. D.
(2010). Rickettsia Sca2 is a bacte-
rial formin-like mediator of actin-
based motility. Nat. Cell Biol. 12,
1057–1063.
Ieva, R., and Bernstein, H. D. (2009).
Interaction of an autotransporter
passenger domain with BamA dur-
ing its translocation across the bac-
terial outer membrane. Proc. Natl.
Acad. Sci. U.S.A. 106, 19120–19125.
Jain, S., and Goldberg, M. B. (2007).
Requirement for YaeT in the outer
membrane assembly of autotrans-
porter proteins. J. Bacteriol. 189,
5393–5398.
Kespichayawattana,W.,Rattanachetkul,
S.,Wanun,T.,Utaisincharoen,P.,and
Sirisinha, S. (2000). Burkholderia
pseudomallei induces cell fusion and
actin-associated membrane protru-
sion: a possible mechanism for cell-
to-cell spreading. Infect. Immun. 68,
5377–5384.
Kleba, B., Clark, T. R., Lutter, E. I., Elli-
son,D.W.,andHackstadt,T.(2010).
Disruption of the Rickettsia rickettsii
Sca2 autotransporter inhibits actin-
based motility. Infect. Immun. 78,
2240–2247.
Lazar Adler, N. R., Govan, B., Culli-
nane, M., Harper, M., Adler, B., and
Boyce, J. D. (2009). The molecular
and cellular basis of pathogenesis in
melioidosis: how does Burkholderia
pseudomallei cause disease? FEMS
Microbiol. Rev. 33, 1079–1099.
Lehr, U., Schütz, M., Oberhettinger, P.,
Ruiz-Perez,F.,Donald,J.W.,Palmer,
T., Linke, D., Henderson, I. R., and
Autenrieth, I. B. (2010). C-terminal
amino acid residues of the trimeric
autotransporter adhesin YadA of
Yersinia enterocolitica are decisive
for its recognition and assembly by
BamA. Mol. Microbiol. 78, 932–946.
Nishimura, K., Tajima, N., Yoon, Y.
H., Park, S. Y., and Tame, J. R.
(2010). Autotransporter passenger
proteins:virulencefactorswithcom-
mon structural themes. J. Mol. Med.
88, 451–458.
Oomen,C. J.,Van Ulsen,P.,Van Gelder,
P., Feijen, M., Tommassen, J., and
Gros, P. (2004). Structure of the
translocator domain of a bacter-
ial autotransporter. EMBO J. 23,
1257–1266.
Peterson, J. H., Szabady, R. L., and
Bernstein, H. D. (2006). An unusual
signal peptide extension inhibits
the binding of bacterial presecre-
tory proteins to the signal recogni-
tion particle, trigger factor, and the
SecYEG complex. J. Biol. Chem. 281,
9038–9048.
Pilatz, S., Breitbach, K., Hein, N.,
Fehlhaber, B., Schulze, J., Bren-
neke, B., Eberl, L., and Steinmetz,
I. (2006). Identiﬁcation of Burk-
holderiapseudomallei genesrequired
for the intracellular life cycle and
in vivo virulence. Infect. Immun. 74,
3576–3586.
Ruiz-Perez, F., Henderson, I. R., Ley-
ton, D. L., Rossiter, A. E., Zhang,
Y., and Nataro, J. P. (2009). Roles
of periplasmic chaperone proteins
in the biogenesis of serine pro-
tease autotransporters of Enter-
obacteriaceae. J. Bacteriol. 191,
6571–6583.
Sauri, A., Soprova, Z., Wickström, D.,
De Gier,J.W.,Van Der Schors,R. C.,
Smit,A.B.,Jong,W.S.,andLuirink,J.
(2009). The Bam (Omp85) complex
is involved in secretion of the auto-
transporter haemoglobin protease.
Microbiology 155, 3982–3991.
Schell, M. A., Lipscomb, L., and
DeShazer, D. (2008). Comparative
genomics and an insect model
rapidly identify novel virulence
genes of Burkholderia mallei. J. Bac-
teriol. 190, 2306–2313.
Schell, M. A., Ulrich, R. L., Ribot, W.
J., Brueggemann, E. E., Hines, H. B.,
Chen, D., Lipscomb, L., Kim, H. S.,
Mrázek,J.,Nierman,W.C.,andDeS-
hazer, D. (2007). Type VI secretion
is a major virulence determinant in
Burkholderia mallei. Mol. Microbiol.
64, 1466–1485.
Sitthidet, C., Korbsrisate, S., Layton,
A. N., Field, T. R., Stevens, M. P.,
and Stevens, J. M. (2011). Identi-
ﬁcation of motifs of Burkholderia
pseudomallei BimA required for
intracellular motility, actin binding
and actin polymerization. J. Bacte-
riol. 193, 1901–1910.
Sitthidet,C.,Stevens,J. M.,Chantratita,
N.,Currie,B. J.,Peacock,S. J.,Korb-
srisate,S.,and Stevens,M. P. (2008).
Prevalence and sequence diversity
of a factor required for actin-based
motility in natural populations of
Burkholderia species. J. Clin. Micro-
biol. 46, 2418–2422.
Sitthidet, C., Stevens, J. M., Field, T. R.,
Layton, A. N., Korbsrisate, S., and
Stevens, M. P. (2010). Actin-based
motility of Burkholderia thailanden-
sis requires a central acidic domain
of BimA that recruits and activates
the cellular Arp2/3 complex. J. Bac-
teriol. 192, 5249–5252.
Stevens,J.M.,Galyov,E.E.,andStevens,
M. P. (2006). Actin-dependent
movement of bacterial pathogens.
Nat. Rev. Microbiol. 4, 91–101.
Stevens,J.M.,Ulrich,R.L.,Taylor,L.A.,
Wood,M. W.,DeShazer,D.,Stevens,
M. P., and Galyov, E. E. (2005a).
Actin-binding proteins from Burk-
holderia mallei and Burkholderia
thailandensis can functionally com-
pensate for the actin-based motility
defect of a Burkholderia pseudoma-
llei bimA mutant. J. Bacteriol. 187,
7857–7862.
Stevens,M. P.,Stevens,J. M.,Jeng,R. L.,
Taylor, L. A., Wood, M. W., Hawes,
P., Monaghan, P., Welch, M. D., and
Galyov, E. E. (2005b). Identiﬁcation
of a bacterial factor required for
actin-based motility of Burkholde-
ria pseudomallei. Mol. Microbiol. 56,
40–53.
Stevens, M. P., Haque, A., Atkins, T.,
Hill, J., Wood, M. W., Easton, A.,
Nelson, M., Underwood-Fowler, C.,
Titball, R. W., Bancroft, G. J., and
Galyov,E. E. (2004). Attenuated vir-
ulence and protective efﬁcacy of a
Burkholderia pseudomallei bsa type
IIIsecretionmutantinmurinemod-
els of melioidosis. Microbiology 150,
2669–2676.
Frontiers in Microbiology | Cellular and Infection Microbiology July 2011 | Volume 2 | Article 151 | 6Lazar Adler et al. Autotransporters of B. pseudomallei and B. mallei
Stevens, M. P., Wood, M. W., Tay-
lor, L. A., Monaghan, P., Hawes,
P., Jones, P. W., Wallis, T. S., and
Galyov, E. E. (2002). An Inv/Mxi-
Spa-like type III protein secretion
system in Burkholderia pseudoma-
llei modulates intracellular behav-
iourof thepathogen.Mol.Microbiol.
46, 649–659.
Suwannasaen, D., Mahawantung, J.,
Chaowagul, W., Limmathurot-
sakul, D., Felgner, P. L., Davies,
H., Bancroft, G. J., Titball, R.
W., and Lertmemongkolchai, G.
(2011). Human immune responses
to Burkholderia pseudomallei
characterized by protein microar-
ray analysis. J. Infect. Dis. 203,
1001–1011.
Tiyawisutsri, R., Holden, M. T.,
Tumapa, S., Rengpipat, S., Clarke,
S. R., Foster, S. J., Nierman, W.
C., Day, N. P., and Peacock, S. J.
(2007). Burkholderia Hep_Hag
autotransporter (BuHA) proteins
elicit a strong antibody response
during experimental glanders but
nothumanmelioidosis.BMCMicro-
biol. 7, 19. doi: 10.1186/1471-2180-
7-19
Ulrich, M. P., Norwood, D. A., Chris-
tensen, D. R., and Ulrich, R.
L. (2006a). Using real-time PCR
to speciﬁcally detect Burkholde-
ria mallei. J. Med. Microbiol. 55,
551–559.
Ulrich, R. L., Ulrich, M. P., Schell, M.
A., Kim, H. S., and DeShazer, D.
(2006b). Development of a poly-
merase chain reaction assay for the
speciﬁc identiﬁcation of Burkholde-
ria mallei and differentiation from
Burkholderiapseudomallei andother
closely related Burkholderiaceae.
Diagn. Microbiol. Infect. Dis. 55,
37–45.
Van Den Berg, B. (2010). Crys-
tal structure of a full-length
autotransporter. J. Mol. Biol. 396,
627–633.
Wells, T. J., Tree, J. J., Ulett, G.
C., and Schembri, M. A. (2007).
Autotransporter proteins: novel tar-
gets at the bacterial cell sur-
face. FEMS Microbiol. Lett. 274,
163–172.
Whitlock, G. C., Estes, D. M., and
Torres, A. G. (2007). Glanders:
off to the races with Burkholderia
mallei. FEMS Microbiol. Lett. 277,
115–122.
Whitmore, A., and Krishnaswami, C. S.
(1912). An account of the discovery
of a hitherto undescribed infective
disease occurring among the popu-
lation of Rangoon. Ind. Med. Gaz.
47, 262–267.
Conﬂict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 28 April 2011; paper pending
published: 31 May 2011; accepted: 28
June2011;publishedonline:15July2011.
Citation: Lazar Adler NR, Stevens JM,
Stevens MP and Galyov EE (2011) Auto-
transportersandtheirroleinthevirulence
of Burkholderia pseudomallei and Burk-
holderia mallei. Front. Microbio. 2:151.
doi: 10.3389/fmicb.2011.00151
This article was submitted to Frontiers
in Cellular and Infection Microbiology, a
specialty of Frontiers in Microbiology.
Copyright © 2011 Lazar Adler, Stevens,
Stevens and Galyov. This is an open-
access article subject to a non-exclusive
license between the authors and Frontiers
Media SA, which permits use, distribu-
tion and reproduction in other forums,
provided the original authors and source
are credited and other Frontiers condi-
tions are complied with.
www.frontiersin.org July 2011 | Volume 2 | Article 151 | 7